Medical School News and Research

RSS

People with unexplained symptoms can benefit from traditional acupuncture

Attending frequently with medically unexplained symptoms is distressing for both patient and doctor and effective treatment or management options are limited: one in five patients have symptoms that remain unexplained by conventional medicine.

30 May 2011

New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting

UCB today announced data which showed that the addition of Cimzia to current therapy was associated with a rapid and consistent clinical response in a diverse group of rheumatoid arthritis (RA) patients.

30 May 2011

Ultra bad cholesterol

Bad cholesterol, known as LDL is known to be sticky but this ultra –bad called MGmin-LDL is found to be stickier meaning it's more likely to attach to arterial walls. This is more dangerous because when LDL attaches to artery walls it forms fatty plaques that cause coronary heart disease (CHD). As fatty plaques grow, they narrow the arteries and reduce blood flow and also may trigger a stroke or heart attack. CHD is the most common type of heart disease and kills almost 450,000 Americans each year.

29 May 2011

Research Roundup: Medicaid co-payments, access to docs causes worse health

Disparities In Child Access To Emergency Care For Acute Oral Injury -- This study looked at the "impact of insurance status on dental practices' willingness to schedule an appointment for a child with a symptomatic fractured permanent front tooth." Six researchers posed as mothers of 10-year-old boys who all had the same injury but different coverage: Medicaid/Children's Health Insurance Program (CHIP) or private Blue Cross dental insurance.

27 May 2011

Neurologix presents NLX-P101 Phase 2 trial in Parkinson's disease at 10th INS World Congress

Neurologix, Inc. announced the presentation today of efficacy results through one year of follow-up in patients treated as part of the Company's successful Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease.

27 May 2011

Opinion: How universities can advance global health

"I am glad to see that U.S. research universities, too, now all seem to boast programs in global health. But claiming to have programs in global health is not the same thing as creating programs that can make a difference to populations facing poverty and ill health," Paul Farmer, chair of the Department of Global Health and Social Medicine at Harvard Medical School and founding director of Partners In Health, writes in the Harvard Crimson.

27 May 2011

U-M develops new tool that helps physicians better evaluate patient's depression outcomes

Primary care doctors have long been on the front lines of depression treatment. Depression is listed as a diagnosis for 1 in 10 office visits and primary care doctors prescribe more than half of all antidepressants.

26 May 2011

Paxil and Pravachol in combination cause unexpected increase in blood glucose levels

A widely used combination of two common medications may cause unexpected increases in blood glucose levels, according to a study conducted at the Stanford University School of Medicine, Vanderbilt University and Harvard Medical School. Researchers were surprised at the finding because neither of the two drugs - one, an antidepressant marketed as Paxil, and the other, a cholesterol-lowering medication called Pravachol - has a similar effect alone.

26 May 2011

New cancer study finds benefit in old therapy

Cancer patients who used a 5,000-year-old combination of gentle exercise and meditation experienced significantly higher wellbeing levels, improved cognitive functioning and less inflammation compared to a control group, new University of Sydney research has found.

24 May 2011

Exosome Diagnostics announces expansion of scientific advisory board

Exosome Diagnostics, a leading developer of biofluid based molecular diagnostic tests for use in personalised medicine, today announced the appointments of Bob Carter MD, Carlos Cordon-Cardo MD, PhD, Keith Flaherty MD, John Quackenbush, PhD; to its Scientific Advisory Board (SAB).

24 May 2011

Lifestyle modifications help control blood pressure levels: More evidence

Evidence continues to build that lifestyle modifications help control blood pressure (BP) levels. Data evaluating the consumption of coffee and alcohol and the impact of low fitness levels will be presented at the American Society of Hypertension, Inc.'s 26th Annual Scientific Meeting and Exposition (ASH 2011) and will be featured in the May 22 ASH press briefing.

23 May 2011

New insights into bone diseases

A study by researchers at Children's Hospital Boston and collaborators at other institutions has provided new insights into the means by which bone cells produce new bone in response to mechanical stresses, such as exercise.

23 May 2011

Lilly Phase I multiple myeloma study affirms potential of LY2127399-bortezomib combination

Eli Lilly and Company announced Phase I data on LY2127399, a human monoclonal antibody that neutralizes B-cell activating factor (BAFF), for use in combination with bortezomib in patients with previously-treated multiple myeloma.

21 May 2011

5 Faculty members at Stanford medical school disciplined

Five faculty members at Stanford University's School of Medicine have been disciplined for giving paid promotional speeches for drug companies, a direct violation of school policy.

21 May 2011

APS honors recipients of Clinical Centers of Excellence in Pain Management Awards

The American Pain Society, www.ampainsoc.org, today honored the recipients of its fifth annual Clinical Centers of Excellence in Pain Management Awards recognizing the nation's outstanding pain care centers.

21 May 2011

UM Board of Regents approves $13.7M renovation project for new health care policy institute

A new health care policy institute – one that is expected to become one of the largest of its kind in the nation – will be established at the University of Michigan's North Campus Research Complex.

21 May 2011

Curcumin compound can help head and neck cancer cells overcome resistance to chemotherapy drugs

A primary reason that head and neck cancer treatments fail is the tumor cells become resistant to chemotherapy drugs. Now, researchers at the University of Michigan Comprehensive Cancer Center have found that a compound derived from the Indian spice curcumin can help cells overcome that resistance.

20 May 2011

New technique offers successful bone marrow, organ transplant for patients with autoimmune diseases

University of Minnesota Medical School researchers have discovered a method to quickly and exponentially grow regulatory T-cells - also known as "suppressor cells." The new process enables replication of the cells by tens of millions in several weeks, a dramatic increase over previous duplication methods. Historically, regulatory T-cells have been difficult to replicate.

19 May 2011

NEW Lifestyle on-line teaching modules for medical students

Obesity is an epidemic and when paired with physical inactivity it represents the second leading cause of preventable death nationally from cancer, cardiovascular diseases and diabetes. But in medical school, there is a training gap when it comes to teaching future doctors about obesity and related health problems.

19 May 2011

Face masks worn by TB patients could cut transmission rates to non-infected patients

Face masks worn by patients infected with tuberculosis (TB) may be able to significantly cut transmission rates to non-infected patients, according to a new study by researchers from the U.S. and South Africa. The study was conducted in a specialized airborne infections research facility in South Africa, which was designed to allow study of methods to control the spread of TB.

18 May 2011

Medical School News and Research

People with unexplained symptoms can benefit from traditional acupuncture

New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting

Ultra bad cholesterol

Research Roundup: Medicaid co-payments, access to docs causes worse health

Neurologix presents NLX-P101 Phase 2 trial in Parkinson's disease at 10th INS World Congress

Opinion: How universities can advance global health

U-M develops new tool that helps physicians better evaluate patient's depression outcomes

Paxil and Pravachol in combination cause unexpected increase in blood glucose levels

New cancer study finds benefit in old therapy

Exosome Diagnostics announces expansion of scientific advisory board

Lifestyle modifications help control blood pressure levels: More evidence

New insights into bone diseases

Lilly Phase I multiple myeloma study affirms potential of LY2127399-bortezomib combination

5 Faculty members at Stanford medical school disciplined

APS honors recipients of Clinical Centers of Excellence in Pain Management Awards

UM Board of Regents approves $13.7M renovation project for new health care policy institute

Curcumin compound can help head and neck cancer cells overcome resistance to chemotherapy drugs

New technique offers successful bone marrow, organ transplant for patients with autoimmune diseases

NEW Lifestyle on-line teaching modules for medical students

Face masks worn by TB patients could cut transmission rates to non-infected patients

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News